A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses

Clinical trial NCT01502020 · COMPLETED

Trial details

NCT number: NCT01502020
Sponsor: Actavis Mid-Atlantic LLC
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Actinic Keratoses

Start date: 2011-02-01
Primary completion: 2011-08-01
Enrollment: 410

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.